mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.007 |
mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.008 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.008 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.008 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.008 |
mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.009 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.01 |